BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2022 11:01:13 AM | Browse: 566 | Download: 1861
 |
Received |
|
2022-04-20 20:13 |
|
Peer-Review Started |
|
2022-04-20 20:17 |
|
First Decision by Editorial Office Director |
|
2022-05-30 04:21 |
|
Return for Revision |
|
2022-05-30 04:21 |
|
Revised |
|
2022-06-14 00:24 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-08-09 02:55 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-08-11 04:35 |
|
Articles in Press |
|
2022-08-11 04:35 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-07 03:29 |
|
Publish the Manuscript Online |
|
2022-09-20 11:01 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Case Control Study |
| Article Title |
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic and Milica M Borovcanin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Science and Technological Development of the Republic of Serbia |
175069 |
| Faculty of Medical Sciences, University of Kragujevac |
JP15-05 |
|
| Corresponding Author |
Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, Kragujevac 34000, Serbia. milicaborovcanin@yahoo.com |
| Key Words |
Schizophrenia; Galectin-3; Cytokines; Leukocytes; Antipsychotics |
| Core Tip |
In clinical sampling, there is an urge to place the results of biological measurements in a much broader context. Elevated serum galectin-3 (Gal-3) levels in schizophrenia (SC) have not been studied in relation to other peripheral biomarkers and subsequent neuroinflammation. We found that Gal-3 contributes to ongoing peripheral systemic inflammation and disease duration in patients with SC. All of this may be an underlying indirect immunometabolic mechanism for cognitive performance in patients with SC. |
| Publish Date |
2022-09-20 11:01 |
| Citation |
Minic Janicijevic S, Jovanovic IP, Gajovic NM, Jurisevic MM, Debnath M, Arsenijevic NN, Borovcanin MM. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World J Psychiatry 2022; 12(9): 1183-1193 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i9/1183.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i9.1183 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
